Avaxim 80/Avaxim 160

Avaxim 80/Avaxim 160

vaccine, hepatitis a




Four Star
Concise Prescribing Info
Inactivated, adsorbed, hepatitis A (GBM strain) vaccine
Avaxim 80 Prevention of infection caused by HAV in childn 12 mth to 15 yr. Avaxim 160 Prevention of infection caused by HAV in adults & adolescents ≥16 yr.
Dosage/Direction for Use
IM Avaxim 80 0.5 mL primary dose, followed by a booster dose 6-36 mth later. Avaxim 160 0.5 mL primary dose, followed by a booster dose 6-12 mth or 6-36 mth later. Can also be administered as a booster dose of hepatitis A vaccine after receiving combined typhoid fever & hepatitis A vaccine 6-36 mth earlier.
Hypersensitivity to HAV & neomycin. Postpone vaccination in the event of febrile illness.
Special Precautions
Do not administer IV or intradermally. Patients on immunosuppressants (eg, corticosteroids, cytotoxic drugs, radiotherapy) or in a state of immune deficiency (eg, HIV infection). Patients w/ haemophilia or those easily subjected to bruises or bleeding. Liver disease. May not work properly in patients w/ HAV infection at the time of vaccination. Pregnancy.
Adverse Reactions
Fatigue; pain, redness, oedema or induration at inj site; headache, GI disorders (eg, diarrhoea, abdominal pain); muscular or joint pain; nausea, vomiting; loss of appetite; fever. Avaxim 80 Irritability, insomnia.
Drug Interactions
Immunosuppressants (eg, corticosteroids, cytotoxic drugs, radiotherapy).
ATC Classification
J07BC02 - hepatitis A, inactivated, whole virus ; Belongs to the class of hepatitis viral vaccines.
Avaxim 80: P1S1S3, Avaxim 160: P1S1S3, A
Avaxim 80 vaccine (inj) 80 U
(pre-filled syringe) 0.5 mL x 1's
Avaxim 160 vaccine (inj) 160 U
(pre-filled syringe) 0.5 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in